Survival in pancreatic cancer: the best is yet to come

Gastrointestinal Endoscopy

Volumn 72, Issue 1, 2010, Pages 84-85

  Sauer, Bryan G ^a   Shami, Vanessa M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; GEMCITABINE; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR;

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ENDOSCOPIC ECHOGRAPHY; GENE MUTATION; HUMAN; PANCREAS CANCER; PRIORITY JOURNAL; ADENOCARCINOMA; CANCER REGISTRY; ECHOGRAPHY; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; UNITED STATES;

ADENOCARCINOMA; ENDOSONOGRAPHY; HUMANS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 77953887105     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2010.02.049     Document Type: Editorial

References (15)

1. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER Web site, 2009. Accessed February 10, 2010.
2. Jemal A., Ward E., Hao Y., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
3. Shibata K., Matsumoto T., Yada K., et al. Factors predicting recurrence after resection of pancreatic ductal carcinoma. Pancreas 31 (2005) 69-73
4. Hunt G.C., and Faigel D.O. Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 55 (2002) 232-237
5. Ngamruengphong S., Li F., Zhou Y., et al. EUS and survival in patients with pancreatic cancer: a population-based study. Gastrointest Endosc 72 (2010) 78-83
6. Ulla-Rocha J.L., Alvarez-Prechous A., Paz-Esquete J., et al. The global impact of endoscopic ultrasound (EUS) regarding the survival of a pancreatic adenocarcinoma in a tertiary hospital. J Gastrointest Cancer (2010 Feb 18) [Epub ahead of print]
7. Burris III H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (1997) 2403-2413
8. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 (1993) 1365-1371
9. Canto M.I., Goggins M., Yeo C.J., et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2 (2004) 606-621
10. Tsunoda T., Yamamoto Y., Kimoto M., et al. Staging and treatment for patients with pancreatic cancer: how small is an early pancreatic cancer?. J Hepatobiliary Pancreat Surg 5 (1998) 128-132
11. Giovannini M., Hookey L.C., Bories E., et al. Endoscopic ultrasound elastography: the first step towards virtual biopsy?. preliminary results in 49 patients. Endoscopy 38 (2006) 344-348
12. Hocke M., Schulze E., Gottschalk P., et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 12 (2006) 246-250
13. Sakamoto H., Kitano M., Suetomi Y., et al. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 34 (2008) 525-532
14. Farrell J.J., van Rijnsoever M., and Elsaleh H. Early detection markers in pancreas cancer. Cancer Biomark 1 (2005) 157-175
15. Stathis A., and Moore M.J. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7 (2010) 163-172